Can-Fite Biopharma Ltd ADR (CANF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -14,443 | -12,625 | -6,571 | -6,433 | -7,024 |
| Depreciation Amortization | 12 | 14 | 14 | 19 | 18 |
| Accounts receivable | 4,275 | 270 | -853 | -2,907 | -1,367 |
| Accounts payable and accrued liabilities | -1,874 | 573 | 769 | 1,199 | 592 |
| Other Working Capital | 2,001 | 935 | 1,134 | -1,997 | -451 |
| Other Operating Activity | -2,034 | -251 | 1,352 | 1,147 | -699 |
| Operating Cash Flow | $-12,063 | $-11,084 | $-4,155 | $-8,972 | $-8,931 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -26 | -3 | -33 | -29 | -10 |
| Investing Cash Flow | $-26 | $-3 | $-33 | $-29 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,683 | 10,167 | 4,387 | 4,474 | N/A |
| Financing Cash Flow | $17,683 | $10,167 | $4,387 | $4,474 | $N/A |
| Exchange Rate Effect | -23 | 2 | -89 | -83 | -116 |
| Beginning Cash Position | 2,697 | 3,615 | 3,505 | 8,115 | 17,172 |
| End Cash Position | 8,268 | 2,697 | 3,615 | 3,505 | 8,115 |
| Net Cash Flow | $5,571 | $-918 | $110 | $-4,610 | $-9,057 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,063 | -11,084 | -4,155 | -8,972 | -8,931 |
| Capital Expenditure | -26 | -3 | -33 | -7 | -10 |
| Free Cash Flow | -12,089 | -11,087 | -4,188 | -8,979 | -8,941 |